Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions
Yan Zhong, Jingfeng Liu
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
Fatemeh Dehghan, Yekta Metanat, Mandana Askarizadeh, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 3
Cancer-associated fibroblasts in hepatocellular carcinoma: heterogeneity, mechanisms and therapeutic targets
Yutong Li, Mawieh Hamad, Eyad Elkord
Hepatology International (2025)
Closed Access
A new therapeutic pathway in autoimmune diseases: chimeric antigen receptor T cells (CAR-T) targeting specific cell subtypes or antigen-specific B lymphocytes—a brief review
María Fernanda Segovia, Diana Landoni, Yohana Defranchi, et al.
Exploration of Immunology (2025) Vol. 5
Open Access
The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances
Paula Morcillo-Martín-Romo, Javier Valverde-Pozo, María Ortiz-Bueno, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 857-857
Open Access
CAR-NK cell therapy: promise and challenges in solid tumors
Sahar Balkhi, Gaia Zuccolotto, Antimo Di Spirito, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Immunotherapy in chronic lymphocytic leukemia: advances and challenges
Pan Gao, Yang Zhang, Jun Ma, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Antitumor and immunomodulatory activities of diphyllin and its derivatives
Yulin Ren, Judith C. Gallucci, Jianhua Yu, et al.
Bioorganic & Medicinal Chemistry (2025), pp. 118197-118197
Closed Access
CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges
Wangshu Li, Xiuying Wang, Xu Zhang, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 1035-1035
Open Access | Times Cited: 3
Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects
Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives
Sana Ahuja, Sufian Zaheer
Korean Journal of Clinical Oncology (2024) Vol. 20, Iss. 2, pp. 51-73
Closed Access | Times Cited: 2
CAR-T Cells in the Treatment of Nervous System Tumors
Ugo Testa, Germana Castelli, Elvira Pelosi
Cancers (2024) Vol. 16, Iss. 16, pp. 2913-2913
Open Access
Chimeric antigen receptor-natural killer (CAR-NK) cell immunotherapy: A bibliometric analysis from 2004 to 2023
Wangshu Li, Jiuxiang Feng, Jianan Peng, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Modulating immune responses for enhanced cell therapies: The dual role of multi-scale biomaterials
Jianan Zeng, Yuhong Jin, Yanxiao Ao, et al.
Deleted Journal (2024) Vol. 1, Iss. 3, pp. 100038-100038
Open Access
Emerging Technologies for the Assessment of Natural Killer Cell Activity
Anna Luise Grab, Alexander Nesterov‐Mueller
J — Multidisciplinary Scientific Journal (2024) Vol. 7, Iss. 4, pp. 457-471
Open Access
Advances in CAR NK Cell Therapy for Targeting and Eradicating Circulating Tumor Cells: Challenges and Solutions for Aging Patients Mini Review
Dmitri Toren, Eugen Ursu, Bogdan Ghilic-Micu, et al.
Ageing & Longevity (2024), Iss. 4 2024, pp. 157-173
Open Access
Effective targeting of CD19 positive primary B-ALL cells using CAR-NK cells generated with mRNA-LNPs
Hossein Salehi-Shadkami, Mosslim Sedghi, Shima Tavoosi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Efficacy of Chimeric Antigen Receptor Engineered Natural Killer Cells in the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis of Preclinical Studies
Donald Bastin, Marisa K. Kilgour, Risa Shorr, et al.
Cytotherapy (2024)
Closed Access
Natural killer cell-based therapies in neuroblastoma
Abtin Ghasempour, Rashin Mohseni, Pouya Mahdavi Sharif, et al.
Cellular Immunology (2024) Vol. 407, pp. 104898-104898
Closed Access
Page 1

Scroll to top